[Effect on the organs and blood of experimental animals, body distribution and excretion of the antineoplastic antibiotic tauromycetin].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D001646:Bile / Q000032:analysis; D003864:Depression, Chemical; D004064:Digestive System / Q000187:drug effects* / Q000473:pathology; D004285:Dogs; D004906:Erythrocyte Count; D006410:Hematopoiesis / Q000187:drug effects*; D006454:Hemoglobins / Q000032:analysis; D007275:Injections, Intravenous; D007668:Kidney / Q000032:analysis* / Q000187:drug effects* / Q000473:pathology; D007964:Leukocytosis / Q000139:chemically induced; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008168:Lung / Q000032:analysis; D008231:Lymphopenia; D009206:Myocardium / Q000032:analysis; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000032:analysis; D013268:Stimulation, Chemical; D013921:Thrombocytopenia / Q000139:chemically induced
D000903:Antibiotics, Antineoplastic; D006454:Hemoglobins
Deĭstvie na organyi i krov' éksperimental'nykh zhivotnykh, raspredelenie po organizmu i vydelenie protivoopukholevogo antibiotika tavromitsetina.